286 related articles for article (PubMed ID: 27837031)
1. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
[TBL] [Abstract][Full Text] [Related]
2. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
3. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
4. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.
Medjkane S; Perez-Sanchez C; Gaggioli C; Sahai E; Treisman R
Nat Cell Biol; 2009 Mar; 11(3):257-68. PubMed ID: 19198601
[TBL] [Abstract][Full Text] [Related]
5. The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras
Leal AS; Misek SA; Lisabeth EM; Neubig RR; Liby KT
Sci Rep; 2019 May; 9(1):7072. PubMed ID: 31068602
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
Sisson TH; Ajayi IO; Subbotina N; Dodi AE; Rodansky ES; Chibucos LN; Kim KK; Keshamouni VG; White ES; Zhou Y; Higgins PD; Larsen SD; Neubig RR; Horowitz JC
Am J Pathol; 2015 Apr; 185(4):969-86. PubMed ID: 25681733
[TBL] [Abstract][Full Text] [Related]
7. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
[TBL] [Abstract][Full Text] [Related]
8. Transcription of HOTAIR is regulated by RhoC-MRTF-A-SRF signaling pathway in human breast cancer cells.
He H; Wei Z; Du F; Meng C; Zheng D; Lai Y; Yao H; Zhou H; Wang N; Luo XG; Ma W; Zhang TC
Cell Signal; 2017 Feb; 31():87-95. PubMed ID: 28069441
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of arginyltransferase 1 induces transcriptional activity of myocardin-related transcription factor A (MRTF-A) and promotes directional migration.
Eisenach PA; Schikora F; Posern G
J Biol Chem; 2014 Dec; 289(51):35376-87. PubMed ID: 25381249
[TBL] [Abstract][Full Text] [Related]
10. RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.
Hayashi K; Watanabe B; Nakagawa Y; Minami S; Morita T
PLoS One; 2014; 9(2):e89016. PubMed ID: 24558465
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A.
Watanabe B; Minami S; Ishida H; Yoshioka R; Nakagawa Y; Morita T; Hayashi K
PLoS One; 2015; 10(8):e0136242. PubMed ID: 26295164
[TBL] [Abstract][Full Text] [Related]
12. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
13. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.
Collisson EA; Kleer C; Wu M; De A; Gambhir SS; Merajver SD; Kolodney MS
Mol Cancer Ther; 2003 Oct; 2(10):941-8. PubMed ID: 14578459
[TBL] [Abstract][Full Text] [Related]
15. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
16. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
17. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
[TBL] [Abstract][Full Text] [Related]
18. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.
Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K
Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220
[TBL] [Abstract][Full Text] [Related]
19. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
Haak AJ; Tsou PS; Amin MA; Ruth JH; Campbell P; Fox DA; Khanna D; Larsen SD; Neubig RR
J Pharmacol Exp Ther; 2014 Jun; 349(3):480-6. PubMed ID: 24706986
[TBL] [Abstract][Full Text] [Related]
20. RhoC expression and head and neck cancer metastasis.
Islam M; Lin G; Brenner JC; Pan Q; Merajver SD; Hou Y; Kumar P; Teknos TN
Mol Cancer Res; 2009 Nov; 7(11):1771-80. PubMed ID: 19861405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
